Current NDC auxiliary source row compounder:4680

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 26436-5343
Product Ndc: 26436-5343
Product Ndc Digits: 264365343
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Estriol
Proprietary Name Suffix: [empty]
Nonproprietary Name: Estriol
Dosage Form Name: CAPSULE
Route Name: ORAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Hybrid Pharma
Establishment Name: Hybrid Pharma
Establishment Fei: [empty]
Substance Name: ESTRIOL
Active Ingredients Info: 2 mg
History Active Ingredients Raw: ESTRIOL
History Active Ingredients Info Raw: 2 mg
History Dosage Raw: CAPSULE
Dea Schedule: [empty]
Package Ndc Raw: 26436-5343-1
Package Ndc: 26436-5343-1
Package Ndc Digits: 2643653431
Package Ndc11: 26436534301
Package Description: 100 CAPSULE in 1 VIAL, PLASTIC (26436-5343-1)
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:4680
Source Row Number: 4680
Source Row Hash: 5c089c8662b4b0d12dd18e227c01625b9a37ccb665c1e661eec827c203143944
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "ORAL",
    "PRODUCTNDC": "26436-5343",
    "DEASCHEDULE": "",
    "LABELERNAME": "Hybrid Pharma",
    "SUBSTANCENAME": "ESTRIOL",
    "DOSAGEFORMNAME": "CAPSULE",
    "NDCPACKAGECODE": "26436-5343-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Estriol",
    "REPORTINGPERIOD": "2024-2",
    "NONPROPRIETARYNAME": "Estriol",
    "PACKAGEDESCRIPTION": "100 CAPSULE in 1 VIAL, PLASTIC (26436-5343-1) ",
    "ACTIVEINGREDIENTSINFO": "2 mg",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:4680
Source Row Number: 4680
Status Scope: package
Lookup Ndc: 26436-5343-1
Lookup Ndc Digits: 2643653431
Product Ndc: 26436-5343
Product Ndc Digits: 264365343
Package Ndc: 26436-5343-1
Package Ndc Digits: 2643653431
Package Ndc11: 26436534301
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2024-2
Reporting Period: 2024-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 5c089c8662b4b0d12dd18e227c01625b9a37ccb665c1e661eec827c203143944
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33